Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Gergel Ivan
 2. Date of Event Requiring Statement (Month/Day/Year)
05/19/2005		 3. Issuer Name and Ticker or Trading Symbol
FOREST LABORATORIES INC [FRX]
(Last)
(First)
(Middle)
C/O FOREST LABORATORIES, INC., 909 THIRD AVENUE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Sr VP - Chief Sci. Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

NEW YORK, NY 10022		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 0
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) 05/22/2001(1) 05/22/2006 Common Stock 4,740 $ 21.086 D  
Stock Option (Right to Buy) 05/22/2001(2) 05/22/2006 Common Stock 11,260 $ 21.086 D  
Stock Option (Right to Buy) 12/14/2002(3) 12/14/2011 Common Stock 18,380 $ 38.145 D  
Stock Option (Right to Buy) 12/14/2006 12/14/2011 Common Stock 2,620 $ 38.145 D  
Stock Option (Right to Buy) 12/13/2003(4) 12/13/2012 Common Stock 27,932 $ 48.34 D  
Stock Option (Right to Buy) 12/13/2007 12/13/2012 Common Stock 2,068 $ 48.34 D  
Stock Option (Right to Buy) 12/12/2004(5) 12/12/2013 Common Stock 13,306 $ 59.05 D  
Stock Option (Right to Buy) 12/12/2006(6) 12/12/2013 Common Stock 1,694 $ 59.05 D  
Stock Option (Right to Buy) 12/13/2005(7) 12/13/2014 Common Stock 12,648 $ 42.535 D  
Stock Option (Right to Buy) 12/13/2005(8) 12/13/2014 Common Stock 2,352 $ 42.535 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Gergel Ivan
C/O FOREST LABORATORIES, INC.
909 THIRD AVENUE
NEW YORK, NY 10022		       Sr VP - Chief Sci. Officer  

Signatures

Ivan Gergel 05/27/2005
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The option is currently exercisable as to 4,700 shares.
(2) The option is currently exercisable as to 11,260 shares.
(3) The option is currently exercisable as to 4,500 shares, and will become exercisable as to an additional 4,500 shares on 12/14/2005 and as to the remaining 9,380 shares on 12/14/06.
(4) The option is currently exercisable as to 9,000 shares, and will become exercisable as to an additional 4,500 shares on each of 12/13/2005 and 12/13/2006 and as to the remaining 9,932 shares on 12/13/2007.
(5) The option is currently exercisable as to 2,250 shares, and will become exercisable as to an additional 2,250 shares on 12/12/2005, as to 2,249 shares on 12/12/2006, as to 2,250 shares on 12/12/2007 and as to the remaining 4,307 shares on 12/12/2008.
(6) The option will become exercisable as to 1 share on 12/12/2006 and as to the remaining 1,693 shares on 12/12/2008.
(7) The option will become exercisable as to 2,249 shares on 12/13/2005 and as to 2,250 shares on each of 12/13/2006, 12/13/2007 and 12/13/2008 and as to the remaining 3,649 shares on 12/13/2009.
(8) The option will become exercisable as to 1 share on 12/13/2005 and as to the remaining 2,351 shares on 12/13/2009.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.